Yousif Capital Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EB
AIM
AAMU
AAIS
BCAM
JWM
P
SAM
Yousif Capital Management's DGX Position: Q2 2026 in Review
Yousif Capital Management reduced its Quest Diagnostics (DGX) stake by 19% in Q2 2026, selling an estimated $677K and leaving 15,051 shares worth $3.19M. The position accounts for 0.04% of the portfolio, ranked #464.
Yousif Capital Management first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.72M in Q4 2021. 239 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Yousif Capital Management held 15,051 shares of Quest Diagnostics worth $3.19M as of Q2 2026.
- Yousif Capital Management sold 3,447 Quest Diagnostics shares in Q2 2026, an estimated $677K.
- Quest Diagnostics made up 0.04% of Yousif Capital Management's portfolio in Q2 2026, its #464 holding.
- Yousif Capital Management first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
- Yousif Capital Management's Quest Diagnostics position peaked at $4.72M in Q4 2021.
- 239 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.